1. Nakayama H, Jorgensen HS, Raaschou HO, Olsen TS. Recovery of upper extremity function in stroke patients: the Copenhagen Stroke Study. Arch Phys Med Rehabil. 1994; 75:394–398. PMID:
8172497.
Article
2. Duncan PW, Wallace D, Studenski S, Lai S, Johnson D. Conceptualization of a new stroke-specific outcome measure: the stroke impact scale. Top Stroke Rehabil. 2001; 8:19–33. PMID:
14523743.
Article
3. Sehgal N, McGuire JR. Beyond Ashworth. Electrophysiologic quantification of spasticity. Phys Med Rehabil Clin N Am. 1998; 9:949–979. PMID:
9894105.
Article
4. Katz RT, Rymer WZ. Spastic hypertonia: mechanisms and measurement. Arch Phys Med Rehabil. 1989; 70:144–155. PMID:
2644919.
5. Cardoso E, Pedreira G, Prazeres A, Ribeiro N, Melo A. Does botulinum toxin improve the function of the patient with spasticity after stroke. Arq Neuropsiquiatr. 2007; 65:592–595. PMID:
17876396.
Article
6. Barwood S, Baillieu C, Boyd R, Brereton K, Low J, Nattrass G, Graham HK. Analgesic effects of botulinum toxin A: a randomized, placebo-controlled clinical trial. Dev Med Child Neurol. 2000; 42:116–121. PMID:
10698329.
Article
7. Rousseaux M, Kozlowski O, Froger J. Efficacy of botulinum toxin A in upper limb function of hemiplegic patients. J Neurol. 2002; 249:76–84. PMID:
11954872.
Article
8. Lagalla G, Danni M, Reiter F, Ceravolo MG, Provinciali L. Post-stroke spasticity management with repeated botulinum toxin injections in the upper limb. Am J Phys Med Rehabil. 2000; 79:377–384. PMID:
10892624.
Article
9. Chaussy C, Brendel W, Schmiedt E. Extracorporeally induced destruction of kidney stone by shock waves. Lancet. 1980; 2:1265–1268. PMID:
6108446.
10. Valchanou VD, Michailov P. High energy shock waves in the treatment of delayed and nonunion of fractures. Int Orthop. 1991; 15:181–184. PMID:
1743828.
Article
11. Rompe JD, Zoellner J, Nafe B. Shock wave therapy versus conventional surgery in the treatment of calcifying tendinitis of the shoulder. Clin Orthop Relat Res. 2001; 387:72–82. PMID:
11400897.
Article
12. Rompe JD, Hopf C, Kullmer K, Heine J, Burger R. Analgesic effect of extracorporeal shock-wave therapy on chronic tennis elbow. J Bone Joint Surg Br. 1996; 78:233–237. PMID:
8666632.
Article
13. Rompe JD, Decking J, Schoellner C, Nafe B. Shock wave application for chronic plantar fasciitis in running athletes. A prospective, randomized, placebocontrolled trial. Am J Sports Med. 2003; 31:268–275. PMID:
12642264.
Article
14. Mariotto S, Cavalieri E, Amelio E, Ciampa AR, de Prati AC, Marlinghaus E, Russo S, Suzuki H. Extracorporeal shock waves: from lithotripsy to anti-inflammatory action by NO production. Nitric Oxide. 2005; 12:89–96. PMID:
15740982.
Article
15. Kimura J. Electrodiagnosis in diseases of nerve and muscle: principles and practice. 2001. UK: University of Oxford;p. 439–465.
16. Eisen A, Odusote K. Amplitude of the F-wave: a potential means of documenting spasticity. Neurology. 1979; 29:1306–1309. PMID:
573413.
17. Milanov I. Examination of the segmental pathophysiological mechanisms of spasticity. Electromyogr Clin Neurophysiol. 1994; 34:73–79. PMID:
8187681.
18. Hultborn H, Nielsen J. H-reflexes and F-responses are not equally sensitive to changes in motoneuronal excitability. Muscle Nerve. 1995; 18:1471–1474. PMID:
7477072.
Article
19. Bakheit AM, Maynard VA, Curnow J, Hudson N, Kodapala S. The relationship between Ashworth scale scores and the excitability of the alpha motor neurones in patients with post-stroke muscle spasticity. J Neurol Neurosurg Psychiatry. 2003; 74:646–648. PMID:
12700310.
20. Manganotti P, Amelio E. Long-term effect of shock wave therapy on upper limb hypertonia in patients affected by stroke. Stroke. 2005; 36:1967–1971. PMID:
16109905.
Article
21. Yoo SD, Kim HS, Jung PK. The effect of shock wave therapy on upper limb spasticity in the patients with stroke. J Korean Acad Rehabil Med. 2008; 32:406–410.
22. Han TR, Kim JH, Chun MH. Evaluation of spasticity in hemiplegic patients. J Korean Acad Rehabil Med. 1993; 17:18–25.
23. McDowell I, Newell C. Measuring health; a guide to rating scales and questionnaires. 1987. UK: University of Oxford;p. 229–268.
24. Wang CJ, Huang HY, Pai CH. Shock wave-enhanced neovascularization at the tendon-bone junction: an experiment in dogs. J Foot Ankle Surg. 2002; 41:16–22. PMID:
11858601.
Article
25. Wang CJ, Wang FS, Yang KD, Weng LH, Hsu CC, Huang CS, Yang LC. Shock wave therapy induces neovascularization at the tendon-bone junction. A study in the rabbits. J Orthop Res. 2003; 21:984–999. PMID:
14554209.
26. Seidl M, Steinbach P, Worle K, Hofstadter F. Induction of stress fibres and intercellular gaps in human vascular endothelium by shock-waves. Ultrasonics. 1994; 32:397–400. PMID:
8079400.
Article
27. Molina JA, Jimenez-Jimenez FJ, Orti-Pareja M, Navarro JA. The role of nitric oxide in neurodegeneration. Potential for pharmacological intervention. Drugs Aging. 1998; 12:251–259. PMID:
9571390.
28. Blottner D, Luck G. Just in time and place: NOS/NO system assembly in neuromuscular junction formation. Microsc Res Tech. 2001; 55:171–180. PMID:
11747092.
Article
29. Leone JA, Kukulka CG. Effects of tendon pressure on alpha motoneuron excitability in patients with stroke. Phys Ther. 1988; 68:475–480. PMID:
3353457.
Article